Invitrogen

Invitrogen Corp. Q2 2008 Earnings Call Transcript

Seeking Alpha (Free subscription) | yesterday

Invitrogen Corp. (IVGN) Q2 FY08 Earnings Call Complete Story »

Invitrogen Announces Second Quarter 2008 Financial Results

Business Wire (Free subscription) | 07/24/2008

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN) today announced results for its second quarter ended June 30, 2008. Revenues for the second quarter were

Active Motif, Inc.: Invitrogen and Active Motif Explore Use of FPGA Technology for Next-Generation Sequencing Data Analysis

Market Wire - Pharmaceuticals and Biotech (Free subscription) | 07/21/2008

CARLSBAD, CA (MARKET WIRE) Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, and Active Motif, Inc., developer of TimeLogic(R) hardware-accelerated genomics solutions, have announced a joint project to explore the use of field programmable gate array (FPGA) technology for the analysis of next-generation sequencing data.

• Invitrogen and Active Motif Explore Use of FPGA Technology for Next-Generation Sequencing Data Analysis - The Earth Times Online Newspaper

Another HER2 Test Receives FDA Approval

Medgadget (Free subscription) | 07/16/2008

The FDA has given Invitrogen pre-market approval for company's new test for the HER2 gene, commonly expressed in breast cancer patients. The kit is based on a technology called chromogenic in situ hybridization (CISH). The test uses a DNA probe for the HER2 gene, which is amplified in 18 to 30 percent of breast cancers and predicts whether a breast cancer patient is a candidate for trastuzumab treatment....

Www.OSIRonline.com - markets.pe.com

www.OSIR.org.in (Free subscription) | 07/12/2008

OSIR), Invitrogen Corp. (NASDAQ: IVGN), NeoStem Inc. (AMEX: NBS), and Aastrom Biosciences, Inc. (NASDAQ: ASTM). Put those bad boys along with StemCells Inc. in a Google Portfolio Source: markets.pe.com OSIR | X PRIZE FoundationForum Number of topics in phpBB: 8 Number of posts in phpBB: 54 Private messages login or register to [...]

Invitrogen to Integrate Brendan Technologies' Advanced Analytical Software into Protein Analysis Solutions

Business Wire (Free subscription) | 07/11/2008

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a leading provider of essential life sciences technologies for research, production and diagnostics, announced today

Stock market news and prices (OSIR.org.in)

www.OSIR.org.in (Free subscription) | 07/10/2008

OSIR ), Invitrogen Corp. ( NASDAQ: IVGN ), NeoStem Inc. ( AMEX: NBS ), and Aastrom Biosciences, Inc. ( NASDAQ: ASTM ). Put those bad boys along with StemCells Inc. in a Google Portfolio Source: markets.chron.com OSIR | X PRIZE FoundationForum Number of topics in phpBB: 8 Number of posts in phpBB: [...]

Invitrogen gets breast cancer test approval

Fiercebiotech (Free subscription) | 07/09/2008

Invitrogen has won FDA approval of a test that can determine whether a woman with breast cancer will benefit from Genentech's Herceptin. The SPOT-Light test, as it is known, uses a DNA probe for the HER2 gene, which is amplified in 18 to 30 percent of breast cancers and can predict whether a patient will benefit from Herceptin. While a test is already available for Herceptin, many smaller hospitals...

• FDA OKs Genetic Breast Cancer Test - Health - The Post Chronicle
• Invitrogen wins approval for cancer-gene drug test - San Diego Union
• See the 5 articles on the same subject

Monogram to roll out breast cancer test, compete with Invitrogen

bizjournals (Free subscription) | 07/09/2008

Monogram Biosciences Inc. said it will make its HERmark breast cancer assay available to doctors throughout the United States starting July 15. (MGRM) (IVGN)

Monogram to roll out breast cancer test, compete with Invitrogen

The East Bay Business Times (Free subscription) | 07/09/2008

Monogram Biosciences Inc. said Tuesday that it will make its HERmark breast cancer assay available to doctors throughout the United States starting July 15. (MGRM) (IVGN)

FDA OKs Invitrogen genetic test for breast cancer

Science - The Post Chronicle (Free subscription) | 07/09/2008

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Invitrogen Corp's genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin....

• FDA Approves New Genetic Test for Patients with Breast Cancer - Food and Drug Administration
• FDA OKs Genetic Breast Cancer Test - Health - The Post Chronicle
• See the 4 articles on the same subject

Www.OSIRonline.com - BioSpace - Financial Content

www.OSIR.org.in (Free subscription) | 07/09/2008

OSIR ), Invitrogen Corp. ( NASDAQ: IVGN ), NeoStem Inc. ( AMEX: NBS ), and Aastrom Biosciences, Inc. ( NASDAQ: ASTM ). Put those bad boys along with StemCells Inc. in a Google Portfolio Source: investor.biospace.com Office of Scientific Investigation and ResearchUnofficial Website for The Office of Scientific Investigation and Research, OSIR, [...]

Invitrogen Sets Second Quarter Earnings Release Date for Thursday, July 24, 2008

The Earth Times Online Newspaper (Free subscription) | 07/09/2008

CARLSBAD, Calif. - Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, will announce its second quarter 2008 earnings on Thursday, July 24, 2008, before Market open. Following the earnings release, Invitrogen senio

• FDA Grants Invitrogen Premarket Approval of Breast Cancer Test - Business Wire

Invitrogen Sets Second Quarter Earnings Release Date for Thursday, July 24, 2008

Business Wire (Free subscription) | 07/09/2008

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, will announce its second

Monogram to roll out breast cancer test, compete with Invitrogen

The San Francisco Business Times (Free subscription) | 07/09/2008

Monogram Biosciences Inc. said Tuesday that it will make its HERmark breast cancer assay available to doctors throughout the United States starting July 15. (MGRM) (IVGN)